Scholl, F.A., McLoughlin, P., Ehler, E., dc Giovanni, C. and Schafer, B.W. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Celi Biol 2000; 151: 495-506.
Schreck, R., Albermann, K. and Baeuerle, P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radie Res Commun 1992; 17: 221-237.
Schreck, R., Rieber, P. and Baeucrle, P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EmboJ 1991; 10: 2247-2258.
Schwartz, D., Almog, N., Peled, A., Goldfinger, N. and Rotter, V. Role of wild type p53 in the G2 phase: regulation of the gamma- irradiation-induced delay and DNA repair. Oncogene 1997; 15: 2597-2607.
Schwartz, D., Goldfinger, N. and Rotter, V. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 1993; 8: 1487-1494.
Sedman, J. and Stenlund, A. Co-operative interaction between the initiator El and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. EmboJ 1995; 14: 6218-6228.
Sedman, J. and Stenlund, A. The initiator protein El binds to the bovine papillomavirus origin of replication as a trimeric ring-like structure. Embo J 1996; 15: 5085-5092.
Seewaidt, V.L., Mrozek, K., Dietze, E.C., Parker, M. and Caldwell, L.E. Humań papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis. Cancer Res 2001; 61: 616-624.
Selyakumaran, M., Lin, H.K., Miyashita, T., Wang, H.G., Krajewski, S., Reed, J.C., Hoffman, B. and Liebermann, D. Immediate carly up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 1994; 9: 1791-1798.
Sen, C.K., Roy, S. and Packer, L. lnvolvement of intracellular Ca2+ in oxidant-induced NF-kappa B activation. FEBS Lett 1996; 385: 58-62.
Sen, R. and Baltimore, D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Celi 1986; 46: 705-716.
Seto, E., Usheva, A., Zambetti, G.P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A.J. and Shenk, T. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 1992; 89: 12028-12032.
Shally, M., Alloul, N., Jackman, A., Muller, M., Gissmann, L. and Sherman, L. The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in celi free Systems and bacteria and study of their interaction with p53. Virus Res 1996; 42: 81-96.
Shao, R., Tsai, E.M., Wei, K., von Lindcm, R., Chen, Y.H., Makino, K. and Hung, M.C. El A Inhibition of Radiation-induced NF-kappaB Activity through Suppression of IKK Activity and IkappaB Degradation, Independent of Akt Activation. Cancer Res 2001; 61: 7413-7416.
Shaulsky, G., Goldfinger, N., Peled, A. and Rotter, V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci USA 1991; 88: 8982-8986.
Shaw, P., Freeman, J., Bovey, R. and Iggo, R. Regulation of specific DNA binding by p53: evidence for a role for O- glycosylation and charged residues at the carboxy-terminus. Oncogene 1996; 12: 921-930.
Sheikh, M.S., Burns, T.F., Huang, Y., Wu, G.S., Amundson, S., Brooks, K.S., Fornace, A.J., Jr. and el-Deiry, W.S. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 1998; 58: 1593-1598.
183